spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iancu, C.
Right arrow Articles by Atweh, G. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iancu, C.
Right arrow Articles by Atweh, G. F.

Journal of Cell Science, Vol 114, Issue 5 909-916, Copyright © 2001 by Company of Biologists

JOURNAL ARTICLES

Effects of stathmin inhibition on the mitotic spindle

C Iancu, SJ Mistry, S Arkin, S Wallenstein and GF Atweh
Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA.

Stathmin is a major cytosolic phosphoprotein that plays an important role in the regulation of microtubule dynamics during cell cycle progression. It has recently been proposed that the major function of stathmin is to promote depolymerization of the microtubules that make up the mitotic spindle. In this report, we tested the prediction that a deficiency in stathmin expression would result in constitutive stabilization of microtubules and lead to abnormalities in the organization of the mitotic spindle. Our studies demonstrate that antisense inhibition of stathmin expression in K562 erythroleukemic cells results in increased ratio of polymerized to depolymerized tubulin. These changes are associated with phenotypic abnormalities of the mitotic spindle and difficulty in completing mitosis. These studies also showed that inhibition of stathmin expression results in increased susceptibility of K562 leukemic cells to the pharmacological agents, like taxol, which are known to stabilize the mitotic spindle. In contrast, stathmin inhibition results in decreased sensitivity to vinblastine, an agent that destabilizes the mitotic spindle. Thus, our experimental findings are supportive of the model that stathmin is a microtubule-destabilizing factor that plays an important role in the regulation of the mitotic spindle. We also suggest a potential therapeutic approach for cancer based on the combination of stathmin inhibition with pharmacologic agents that stabilize the mitotic spindle.


This article has been cited by other articles:


Home page
 Mol Cancer ResHome page
S. J. Mistry, A. Bank, and G. F. Atweh
Synergistic Antiangiogenic Effects of Stathmin Inhibition and Taxol Exposure
Mol. Cancer Res., August 1, 2007; 5(8): 773 - 782.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. M.R. Bhat and V. Setaluri
Microtubule-Associated Proteins as Targets in Cancer Chemotherapy
Clin. Cancer Res., May 15, 2007; 13(10): 2849 - 2854.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
P. Holmfeldt, K. Brannstrom, S. Stenmark, and M. Gullberg
Aneugenic Activity of Op18/Stathmin Is Potentiated by the Somatic Q18->E Mutation in Leukemic Cells
Mol. Biol. Cell, July 1, 2006; 17(7): 2921 - 2930.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Honnappa, W. Jahnke, J. Seelig, and M. O. Steinmetz
Control of Intrinsically Disordered Stathmin by Multisite Phosphorylation
J. Biol. Chem., June 9, 2006; 281(23): 16078 - 16083.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
K. Zahedi, M. P. Revelo, S. Barone, Z. Wang, K. Tehrani, D. P. Citron, J. J. Bissler, H. Rabb, and M. Soleimani
Stathmin-deficient mice develop fibrosis and show delayed recovery from ischemic-reperfusion injury
Am J Physiol Renal Physiol, June 1, 2006; 290(6): F1559 - F1567.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
D. C. H. Ng, B. H. Lin, C. P. Lim, G. Huang, T. Zhang, V. Poli, and X. Cao
Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin
J. Cell Biol., January 17, 2006; 172(2): 245 - 257.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
S. Barone, T. Okaya, S. Rudich, S. Petrovic, K. Tenrani, Z. Wang, K. Zahedi, R. A. Casero, A. B. Lentsch, and M. Soleimani
Distinct and sequential upregulation of genes regulating cell growth and cell cycle progression during hepatic ischemia-reperfusion injury
Am J Physiol Cell Physiol, October 1, 2005; 289(4): C826 - C835.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. Giampietro, F. Luzzati, G. Gambarotta, P. Giacobini, E. Boda, A. Fasolo, and I. Perroteau
Stathmin Expression Modulates Migratory Properties of GN-11 Neurons in Vitro
Endocrinology, April 1, 2005; 146(4): 1825 - 1834.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
K. Zahedi, Z. Wang, S. Barone, K. Tehrani, N. Yokota, S. Petrovic, H. Rabb, and M. Soleimani
Identification of stathmin as a novel marker of cell proliferation in the recovery phase of acute ischemic renal failure
Am J Physiol Cell Physiol, May 1, 2004; 286(5): C1203 - C1211.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. Alli, J. Bash-Babula, J.-M. Yang, and W. N. Hait
Effect of Stathmin on the Sensitivity to Antimicrotubule Drugs in Human Breast Cancer
Cancer Res., December 1, 2002; 62(23): 6864 - 6869.
[Abstract] [Full Text] [PDF]


© The Company of Biologists Ltd 2001